date,title,source
Oct-23-18,BioCryst to Report Third Quarter 2018 Financial Results on November 6,GlobeNewswire
Oct-30-18,Earnings Preview: BioCryst Pharmaceuticals (BCRX) Q3 Earnings Expected to Decline,Zacks
Nov-05-18,"BioCryst to Present Abstracts at Annual Scientific Meeting of American College of Allergy, Asthma & Immunology",GlobeNewswire
Nov-06-18,"BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-06-18,BioCryst: 3Q Earnings Snapshot,Associated Press
Nov-06-18,BioCryst Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-07-18,Edited Transcript of BCRX earnings conference call or presentation 6-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Nov-08-18,BioCryst to Present at Upcoming Investor Conferences,GlobeNewswire
Nov-16-18,"BioCryst Presents Data Highlighting the Rapid and Sustained Plasma Concentrations of BCX7353 in HAE Patients at the Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology",GlobeNewswire
Nov-19-18,Edited Transcript of BCRX earnings conference call or presentation 6-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Nov-20-18,BioCryst Appoints Rare Disease Expert Theresa Heggie to Board of Directors,GlobeNewswire
Nov-27-18,"New Research Coverage Highlights Immunomedics, Surmodics, PDF Solutions, Stepan, Express Scripts Holding, and BioCryst Pharmaceuticals  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Dec-17-18,Edited Transcript of BCRX earnings conference call or presentation 6-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Dec-27-18,Stocks down in December for pharma firms in the Triangle,American City Business Journals
Jan-02-19,BioCryst to Present at 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-02-19,BioCryst Initiates Phase 1 Clinical Trial of Galidesivir,GlobeNewswire
Jan-04-19,BioCryst Appoints Steve Aselage to Board of Directors,GlobeNewswire
Feb-05-19,"BioCryst to Present ZENITH-1 Results at American Academy of Allergy, Asthma & Immunology Annual Meeting",GlobeNewswire
Feb-06-19,BioCryst Strengthens Cash Position With Flexible $100 Million Debt Facility,GlobeNewswire
Feb-12-19,"Detailed Research: Economic Perspectives on Callon Petroleum, Summit Materials, Echo Global Logistics, BioCryst Pharmaceuticals, NEXEO SOLUTIONS, and NL Industries  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Feb-14-19,Here Are 5 Biotech Stocks To Love This Valentine's Day: Analyst,Investor's Business Daily
Feb-15-19,"The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings",Benzinga
Feb-25-19,Analysts Estimate BioCryst Pharmaceuticals (BCRX) to Report a Decline in Earnings: What to Look Out for,Zacks
Feb-28-19,BioCryst to Present at Barclays Global Healthcare Conference,GlobeNewswire
Mar-04-19,Edited Transcript of BCRX earnings conference call or presentation 4-Mar-19 1:30pm GMT,Thomson Reuters StreetEvents
Mar-04-19,Biocryst Pharmaceuticals Inc (BCRX) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Mar-04-19,BioCryst Reports Fourth Quarter and Full Year 2018 Financial Results,GlobeNewswire
Mar-04-19,"BioCryst Advancing BCX9930, an Oral Factor D Inhibitor for Complement-Mediated Diseases, into Phase 1 Development",GlobeNewswire
Mar-06-19,"Report: Developing Opportunities within Sarepta Therapeutics, Sally Beauty, Danaher, Ellie Mae, BioCryst Pharmaceuticals, and Akcea Therapeutics  Future Expectations, Projections Moving into 2019",GlobeNewswire
Mar-07-19,Edited Transcript of BCRX earnings conference call or presentation 4-Mar-19 1:30pm GMT,Thomson Reuters StreetEvents
Mar-08-19,Edited Transcript of BCRX earnings conference call or presentation 4-Mar-19 1:30pm GMT,Thomson Reuters StreetEvents
Mar-25-19,"BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX): What Can We Expect From This High Growth Stock?",Simply Wall St.
Apr-01-19,BioCryst to Present at Upcoming Investor Conferences,GlobeNewswire
Apr-04-19,Implied Volatility Surging for BioCryst Pharmaceuticals (BCRX) Stock Options,Zacks
Apr-24-19,BioCryst to Report First Quarter 2019 Financial Results on May 8,GlobeNewswire
May-01-19,Analysts Estimate BioCryst Pharmaceuticals (BCRX) to Report a Decline in Earnings: What to Look Out for,Zacks
May-03-19,"Heres What Hedge Funds Think About BioCryst Pharmaceuticals, Inc. (BCRX)",Insider Monkey
May-06-19,BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),GlobeNewswire
May-08-19,Biocryst Pharmaceuticals Inc (BCRX) Q1 2019 Earnings Call Transcript,Motley Fool
May-08-19,"BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Tops Revenue Estimates",Zacks
May-08-19,BioCryst: 1Q Earnings Snapshot,Associated Press
May-08-19,BioCryst Reports First Quarter 2019 Financial Results,GlobeNewswire
May-09-19,BioCryst Completes Phase 1 Clinical Trial of Galidesivir,GlobeNewswire
May-10-19,BioCryst to Present at Bank of America Merrill Lynch Health Care Conference,GlobeNewswire
May-14-19,Do Options Traders Know Something About BioCryst Pharmaceuticals (BCRX) Stock We Don't?,Zacks
May-21-19,"Why J.C. Penney, Mallinckrodt, and BioCryst Pharmaceuticals Slumped Today",Motley Fool
May-21-19,"In less than six hours today, this Durham company's stock has dropped 50 percent",American City Business Journals
May-21-19,Here's Why BioCryst Pharmaceuticals Collapsed Today,Motley Fool
May-21-19,BioCryst Trades Sharply Lower Despite Acing Late-Stage Hereditary Angioedema Drug Trial,Benzinga
May-21-19,BioCrysts Oral BCX7353 Meets Primary Endpoint in Phase 3 APeX-2 Trial,GlobeNewswire
May-22-19,"The Daily Biotech Pulse: Tocagen Tumbles, OncoSec Offering, Novartis Asthma Combo Drug Study",Benzinga
May-30-19,Here's Why BioCryst Pharmaceuticals Is Soaring Today,Motley Fool
May-31-19,BioCryst to Present at Upcoming Investor Conferences,GlobeNewswire
Jun-04-19,BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),GlobeNewswire
Jun-05-19,Edited Transcript of BCRX earnings conference call or presentation 8-May-19 12:30pm GMT,Thomson Reuters StreetEvents
